New injection aims to block pain for days after cancer surgery
NCT ID NCT07458295
Summary
This study is testing a new, long-acting numbing medicine for pain relief after minimally invasive surgery for gynecologic cancers. Researchers want to see if an injection near the abdominal wall can provide better, longer-lasting pain control than standard options, which could help patients use fewer opioid painkillers and recover more comfortably. The trial will involve about 110 patients who are randomly assigned to receive either the new long-acting injection or a standard pain control method.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.